Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute kidney injury and hydration in frailty

Medicine of older adults · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
AKI with life-threatening complication

Severe hyperkalaemia, pulmonary oedema, refractory acidosis, uraemic encephalopathy or pericarditis, anuria, shock or an infected obstructed urinary tract requires immediate specialist treatment and possible renal replacement therapy.

Action: Use ABCDE and ECG, treat hyperkalaemia and pulmonary oedema immediately, measure bladder volume and urine, obtain urgent renal, electrolyte and gas tests, stop further nephrotoxic exposure and involve nephrology or urology without delaying decompression or critical care.

Synopsis

Detect acute kidney injury despite low muscle mass and non-specific decline, distinguish hypovolaemia from congestion and obstruction, and restore perfusion safely while adjusting medicines, nutrition and community monitoring.

  • Diagnose AKI by creatinine change or urine output using current NICE criteria; a value inside the laboratory range can still represent AKI.
  • First-line assessment reviews previous renal results, urine output, losses, sepsis, bleeding, obstruction, heart failure, medicines and recent contrast or procedures.
  • Examine perfusion and congestion together: blood pressure, refill, mucosa, postural symptoms, jugular venous pressure, oedema, lungs, weight and bladder.
  • Measure post-void residual and obtain renal ultrasound urgently when obstruction is possible or the cause remains unclear under NICE criteria.
  • Urinalysis helps identify blood and protein patterns; send microscopy and renal serology only when intrinsic disease is clinically plausible.
  • For hypovolaemic resuscitation, NICE CG174 uses 500 mL isotonic crystalloid over under 15 minutes, with smaller cautious aliquots and immediate reassessment when frailty, heart or kidney disease limits tolerance.
  • Do not give fluid for a raised creatinine automatically; congested heart failure often needs decongestion rather than hydration.
  • Review NSAIDs, ACE inhibitors, ARBs, diuretics, metformin, SGLT2 inhibitors, anticoagulants, opioids, gabapentinoids and antimicrobials against current physiology and indication.
  • Temporary medicine withholding needs a written restart trigger; failure to restart beneficial treatment after recovery creates long-term harm.
  • After AKI, document cause, peak and recovery, repeat kidney and electrolyte testing, review albuminuria and provide recurrence and sick-day education.

Key red flags

ECG change, muscle weakness or rapidly rising potassium requires emergency hyperkalaemia treatment and monitoring.

Anuria, painful bladder, hydronephrosis or sepsis with obstruction requires urgent urinary drainage and specialist care.

Hypoxia, crackles, raised venous pressure or pulmonary oedema means further routine fluid may be dangerous.

Hypotension, mottling, raised lactate or ongoing losses requires urgent resuscitation with repeated response assessment.

Haematuria, proteinuria, systemic rash, low platelets or inflammatory features raises intrinsic renal disease needing specialist investigation.

Confusion, reduced intake, falls or medicine accumulation may be the first clinical expression of AKI in frailty.

Obstructive pattern

Retention, anuria, palpable bladder or hydronephrosis directs urgent drainage and imaging.

Medicine accumulation

New sedation, bleeding, hypoglycaemia or neurotoxicity follows renal decline without an intentional dose change.

Dialysis-level complication

Refractory potassium, acidosis, pulmonary oedema or uraemic symptoms requires immediate nephrology assessment.

Investigation priorities

01
Serial creatinine and urine outputFirst stepFirst line

Diagnose, stage and follow AKI first line.

Management branches

First-line AKI sequenceConfirm, assess danger and find mechanism

Creatinine rises, urine falls or frailty presents with possible renal accumulation.

  1. Compare baseline and current creatinine and urine output and assess potassium, acidosis, overload, uraemia and shock.
  2. Examine perfusion and congestion, review losses, sepsis, bleeding, medicines and obstruction and obtain targeted urine and imaging tests.
  3. Treat the cause and complication, adjust exposure and record a fluid, urine, laboratory and escalation plan.

Key medicines

Isotonic crystalloid for hypovolaemic resuscitationGive 500 mL intravenously over less than 15 minutes under NICE adult IV-fluid guidance; use smaller aliquots and earlier senior review when frailty, heart failure or kidney disease narrows fluid tolerance.Reassess perfusion, lungs, oxygen, JVP, oedema and urine after every bolus; avoid routine repetition for congested cardiorenal disease or established pulmonary oedema.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG148 acute kidney injuryDetection, obstruction imaging, medicines, referral and post-AKI care.
  • NICE CG174 intravenous fluid therapyResuscitation, maintenance, frailty modification and monitoring.
  • NICE NG5 medicines optimisationReconciliation, adjustment and safe transitions.
  • UK Kidney Association hyperkalaemia guidelineEmergency potassium assessment and treatment pathways.
  • British Geriatrics Society CGA HubFrailty, hydration access, function and community planning.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom